Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
As per available reports about 66 relevant journals, 40 Conferences, 1395 workshops are presently dedicated exclusively to breathing disorder and about 3040 articles are being published on Infectious Diseases.
The environment influences our health in many ways — through exposures to physical, chemical and biological risk factors, and through related changes in our behavior in response to those factors. To answer this question, the available scientific evidence was summarized and more than 100 experts were consulted for their estimates of how much environmental risk factor contribute to the disease burden of 85 diseases. Communicable or infectious diseases are infections transmitted from an infected person, animal or reservoir to another person. These infections can be spread from direct or indirect contact. Knowing how infectious diseases are spread can help minimize the risk of infection. Adopting healthy behaviours can reduce illness. There are simple things you can do to prevent illness.
1. Keep Immunizations up to date
2. Wash your hands often
3. Be aware of what you eat, and be careful how you prepare it
4. Use antibiotics exactly as prescribed
5. Report to your doctor any worsening infection that does not get better after you take a prescribed antibiotic
6. Be cautious around wild and domestic animals that are not familiar to you
7. Avoid areas of insect infestation
8. Avoid unsafe unprotected sex and injection drug use
9. Stay alert to disease threats when you travel
10. When sick, allow yourself time to heal and recover
This report summarizes the results globally, by 14 regions world wide, and separately for children. The evidence shows that environmental risk factors play a role in more than 80% of the diseases regularly reported. Globally, nearly one quarter of all deaths and of the total disease burden can be attributed to the environment. In children, however, environmental risk factors can account for slightly more than one-third of the disease burden. These findings have important policy implications, because the environmental risk factors that were studied largely can be modified by established cost effective interventions. The interventions promote equity by benefiting everyone in the society, while addressing the needs of those most at risk.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Diseases that used to be common in this country and around the world, including polio, measles, diphtheria , pertussis (whooping cough), rubella (German measles), mumps, tetanus, rotavirus and Haemophilus influenza type b (Hib) can now be prevented by vaccination. Thanks to a vaccine, one of the most terrible diseases in history–smallpox–no longer exists outside the laboratory. Over the years vaccines have prevented countless cases of disease and saved millions of lives. Immunity is the body’s way of preventing disease. Children are born with an immune system composed of cells, glands, organs, and fluids located throughout the body. The immune system recognizes germs that enter the body as "foreign invaders” (called antigens) and produces proteins called antibodies to fight them.
The first time a child is infected with a specific antigen (say measles virus), the immune system produces antibodies designed to fight it. This takes time usually the immune system can’t work fast enough to prevent the antigen from causing disease, so the child still gets sick. However, the immune system “remembers” that antigen. If it ever enters the body again, even after many years, the immune system can produce antibodies fast enough to keep it from causing disease a second time. This protection is called immunity.
• Newborn babies are immune to many diseases because they have antibodies they got from their mothers. However, this immunity goes away during the first year of life.
• If an unvaccinated child is exposed to a disease germ, the child's body may not be strong enough to fight the disease. Before vaccines, many children died from diseases that vaccines now prevent such as whooping cough, measles, and polio. Those same germs exist today, but because babies are protected by vaccines, we don’t see these diseases nearly as often.
• Immunizing individual children also helps to protect the health of our community, especially those people who cannot be immunized (children who are too young to be vaccinated, or those who can’t receive certain vaccines for medical reasons), and the small proportion of people who don’t respond to a particular vaccine.
• Vaccine preventable diseases have a costly impact, resulting in doctor's visits, hospitalizations and premature deaths. Sick children can also cause parents to lose time from work.
The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.
Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.
Aug 25-27, 2016 Philadelphia, USA
May 12-13, 2016 Chicago, USA
Aug 1-2, 2016 Frankfurt, Germany
May 2-3, 2016 Chicago, USA
Oct 27-28, 2016 Chicago, USA
March 29-30, 2016 Valencia, Spain
Sept 12-14, 2016 San Antonio, USA
Oct 17-19, 2016 Houston, USA
Oct 3-5, 2016, Miami, USA
10. 5th Virology Conference
Dec 1-3, 2016, Baltimore, USA
11. 2nd Influenza Conference
Sept 12-14, 2016 Berlin, Germany
12. 2nd Parasitology Conference
Oct 10-12, 2016 Manchester, UK
13. 6th Euro Virology Conference
March 10-12, 2016 Madrid, Spain
Oct 17-19, 2016 Dubai, UAE
Oct 3-5, 2016 London, UK
16. 2nd Flu Conference
Nov 17-19, 2016 San Francisco, USA
July 11-12, 2016 Brisbane, Australia
Aug 1-3, 2016 Frankfurt, Germany
May 16-18, 2016 San Antonio, USA
Oct 3-5, 2016 Vancouver, Canada
June 30-Jul 1, 2016 Capetown, South Africa
22. 72nd Allergy, Asthma and Immunology Conference
San Antonio, USA
23. European Clinical Microbiology and Infectious Diseases Conference
24. Infection Prevention and Control Conference
25. 17th Infectious Diseases Conference
26. 34th Annual Infectious Diseases Conference
1. Infectious Diseases Society of America
2. German Centre for Infection Research
3. International Society of Infectious diseases
4. Australasian Society for Infectious Diseases
5. Infectious disease association of California
6. European Society of Clinical Microbiology and Infectious Diseases
7. British Infection Association
8. Society of Tropical Medicine & Infectious Diseases in India
9. Clinical Infectious Diseases Society in India
10. Pediatric Infectious Diseases Society
4. Roche Holding
5. Merck & Co
8. Eli Lilly & Co
9. Abbott Laboratories
12. The Native Antigen Company
This page will be updated regularly.
This page was last updated on 17th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising